IP Library Granted Patent US 8,933,036
Granted Patent B2
US 8,933,036 · App. 13/843,452 · Granted Jan 13, 2015

Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,933,036
App. No.
13/843,452
Granted
Jan 13, 2015
Kind
B2
Abstract

A method of attenuating hair loss includes applying to the hair a composition having an effective amount of a hair-loss attenuating peptide hydrolysate and a cosmetically acceptable carrier.

Claims (24)

1. A method of attenuating hair loss in a human in need thereof comprising:

topically applying to skin comprising hair follicles of the human in need thereof a composition comprising:

an effective amount of a hair-loss attenuating peptide hydrolysate, wherein the peptide hydrolysate is produced from a protease hydrolysis of a protein-rich filtrate collected after cell disruption and elimination by centrifugation or filtration of most of the insoluble membrane components of a Saccharomyces yeast culture, wherein the protein-rich filtrate collected is thereafter adjusted to a generally neutral pH and hydrolyzed by a proteolytic enzyme, and wherein the peptide hydrolysate is composed of peptides each having a molecular weight of less than 6000 Daltons, and

a cosmetically acceptable carrier;

wherein the proteolytic enzyme is selected from papain, bromelain, and ficin or extracted from a microorganism selected from aspergillus, rhizopus , and bacillus;

wherein the peptide hydrolysate increases the expression of keratin 14 in the external sheath cells of hair follicles, increases the expression of collagen IV in the wall of hair follicle blood vessels, increases the expression of protein CD34 in the wall of hair follicle blood vessels, and/or increases the expression of collagen I in the conjunctive tissue sheath and dermal papilla of the hair follicle.

2. The method according to claim 1 wherein the effective amount of the hair-loss attenuating peptide hydrolysate present in the composition is from about 5 to 55 parts per million.

3. The method according to claim 1 wherein the hair-loss attenuating peptide hydrolysate is composed of peptides each having a molecular weight less than 5000 Daltons.

4. The method according to claim 1 wherein the composition is a liquid.

5. The method according to claim 1 wherein the composition is a gel.

6. The method according to claim 1 further comprising applying the composition daily.

7. The method according to claim 6 further comprising applying the composition in an amount effective to increase, on average among a population of persons on whom the composition is applied, an average anagen/telogen ratio of hair from about 10 to about 14 over about 90 days of application.

8. The method according to claim 6 further comprising applying the composition in an amount effective to increase, on average among a population of persons on whom the composition is applied, an average anagen/telogen ratio of hair from about 10 to about 13.8 over about 60 days of application.

9. The method according to claim 6 further comprising applying the composition in an amount effective to increase, on average among a population of persons on whom the composition is applied, an average anagen/telogen ratio of hair from about 10 to about 12 or more over about 30 days of application.

10. The method of claim 1 , wherein the hydrolysis by the proteolytic enzyme proceeds for about two hours at a temperature of about 55° C.

11. The method of claim 1 , wherein the effective amount of a hair-loss attenuating peptide hydrolysate is about 0.05% to about 5% by weight of the composition.

12. The method of claim 1 , wherein the Saccharomyces yeast culture is a Saccharomyces cerevisiae yeast culture.

13. The method of claim 1 , wherein the effective amount of a hair-loss attenuating peptide hydrolysate is 1% by weight of the composition and the composition is applied to a scalp five days per week over a thirty day period.

14. The method of claim 13 , wherein about eight grams of the composition is topically applied per day of the five days.

15. A method of attenuating hair loss in a human in need thereof comprising:

topically applying to skin comprising hair follicles of the human in need thereof a composition comprising:

about 0.05% to about 5% by weight of the composition of a hair-loss attenuating peptide hydrolysate, wherein the peptide hydrolysate is produced from a protease hydrolysis of a protein-rich filtrate collected after cell disruption and elimination by centrifugation or filtration of most of the insoluble membrane components of a Saccharomyces cerevisiae yeast culture, wherein the protein-rich filtrate collected is thereafter adjusted to a generally neutral pH and hydrolyzed by a proteolytic enzyme at a temperature of about 55° C. for about two hours, and wherein the peptide hydrolysate is composed of peptides each having a molecular weight of less than 6000 Daltons, and

a cosmetically acceptable carrier;

wherein the proteolytic enzyme is selected from papain, bromelain, and ficin or extracted from a microorganism selected from aspergillus, rhizopus , and bacillus.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 040842 FRAME: 0847. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jan 11, 2017
From: LIFEHEALTH, LLC
To: SIMCAH PARTNERS, L.P.
Reel/Frame 041329/0164 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 040843 FRAME: 0325. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jan 11, 2017
From: THE MICHAEL N. SINSHEIMER REVOCABLE TRUST U/A
To: SIMCAH PARTNERS, L.P.
Reel/Frame 041328/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2014
From: COQUET, CORINNE; GONDRAN, CATHERINE; PORTOLAN, FREDERIQUE
To: ISP INVESTMENTS INC.
Reel/Frame 031994/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2013
From: DAL FARRA, CLAUDE; BOTTO, JEAN-MARIE; DOMLOGE, NOUHA
To: ISP INVESTMENTS INC.
Reel/Frame 030356/0415 →